Catapult Capital Management’s Allergan Inc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q4
Sell
-55,000
Closed -$9.8M 279
2014
Q3
$9.8M Sell
55,000
-14,016
-20% -$2.33M 1.05% 17
2014
Q2
$11.7M Buy
69,016
+4,016
+6% +$625K 1.31% 11
2014
Q1
$8.07M Sell
65,000
-20,000
-24% -$2.44M 1.61% 7
2013
Q4
$9.44M Buy
+85,000
New +$8.12M 2.25% 6

Other funds holding AGN

Catapult Capital Management's AGN Position: Q4 2014 in Review

Catapult Capital Management sold out of Allergan Inc (AGN) in Q4 2014, closing a stake of 55,000 shares — an estimated $9.8M sold.

Catapult Capital Management first reported a position in AGN in Q4 2013 and held it in 4 quarters. The position peaked at $11.7M in Q2 2014. 819 funds tracked by Wall St. Rank hold AGN as of Q4 2014.

  • Catapult Capital Management reported no remaining Allergan Inc position as of Q4 2014 after selling out during the quarter.
  • Catapult Capital Management sold 55,000 Allergan Inc shares in Q4 2014, an estimated $9.8M.
  • Catapult Capital Management first reported a position in Allergan Inc in Q4 2013 and held it in 4 quarters.
  • Catapult Capital Management's Allergan Inc position peaked at $11.7M in Q2 2014.
  • 819 funds tracked by Wall St. Rank held Allergan Inc as of Q4 2014.

Based on Catapult Capital Management's 13F filing for Q4 2014, filed 17 Feb 2015.